ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2026
Organic acid-associated antimicrobial and antibiofilm activity of Lactobacillus rhamnosus ATCC 7469 against Acinetobacter baumannii and Staphylococcus aureus.
Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Considering the relevance of biofilms in bacterial resistance and the need for innovative therapies against pathogenic microorganisms, alternative strategies using probiotics as antimicrobial agents have emerged. This study aimed to evaluate the antimicrobial and antibiofilm activities of the cell-free supernatant (CFS) of Lactobacillus rhamnosus ATCC 7469 against biofilm-forming strains of Acinetobacter baumannii and Staphylococcus aureus. The activity of CFS was evaluated against A. baumannii ATCC 19606, A. baumannii 301, S. aureus ATCC 12598, and S. aureus ATCC 29213. Antimicrobial activity against planktonic cells, inhibition of biofilm formation, and destruction of mature biofilms were assessed at different CFS dilutions. The corresponding concentrations of lactic and acetic acids were determined by high-performance liquid chromatography (HPLC). CFS showed high antimicrobial activity, with growth inhibition ranging from 88.26% to 100% at the two highest concentrations tested (197.8/108.7 and 107.0/54.5 mM lactic/acetic acid). At 57.8/28.3 mM, growth inhibition ranged from 60.05% to 81.65%, whereas at 27.2/13.5 mM it ranged from 21.12% to 41.03%. CFS also strongly inhibited biofilm formation, with inhibition rates ranging from 66.17% to 100%, whereas destruction of mature biofilms ranged from 24.75% to 88.11%. HPLC analysis demonstrated the presence of lactic and acetic acids in the CFS, with lactic acid being the predominant organic acid detected. Neutralization of the CFS to pH 7.0 markedly reduced its antimicrobial and antibiofilm activities, supporting an important contribution of acidity and acid-associated components to the observed effects. Overall, L. rhamnosus ATCC 7469 CFS exhibited substantial antimicrobial and antibiofilm activity against A. baumannii and S. aureus, supporting further investigation of Lactobacillus-derived CFS as a potential local antimicrobial strategy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.